The deadline to get money back as part of a $4.5 million class action settlement involving certain Robitussin products is ...

Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the product as “non-drowsy” despite containing an ingredient that could cause sleepiness, TopClassAction ...

The recall includes two lots of Children's Robitussin Honey Cough and Chest ... a lack of energy and enthusiasm; severe dizziness or drowsiness; slow heart rate; fainting; psychotic behaviour ...

Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC ...

(CNN) - Some Robitussin Honey products sold nationwide are being recalled ... In immunocompromised people, use of the products could result in “severe or life-threatening adverse events such as ...

According to the FDA, GSK Consumer Healthcare is voluntarily recalling two lots of Children's Robitussin® Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp® Cold and Cough.

Lots "02177" and "02178" for Children's Robitussin Honey Cough and Chest Congestion DM (4 ounces), expiring January 2022. Lot "CL8292" for Children's Dimetapp Cold and Cough (8 ounces), expiring ...